Publication Year: 2016
-
Costs and Outcomes Comparison of Tissue and Blood Based Biopsies for the Purpose of Biomarker Testing for Advanced Non-Small Cell Lung Cancer
-
Blood-based Profiling of NSCLC with CLIA certified cell-free DNA Tests for EGFR, KRAS and BRAF Point Mutations and Utility in Clinical Practice
-
A mass spectrometry-based serum test to predict outcome of treatment with nivolumab: Analysis of samples taken during therapy
-
Profiling Blood from NSCLC Patients for Clinically Actionable Gene Variants using GeneStrat
-
Continuing Development of BDX003 a Serum-based MALDI-TOF Test to Detect Hepatocellular Carcinoma in High-risk Patients